Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health disorder affecting focus and attention that begins in childhood and often continues into adulthood. ADHD symptoms can impact quality of life and are usually treated with medications and/or behavioural strategies. Rates of ADHD medication use in young females has doubled in Canada since 2020. This means that more people must decide whether to continue their ADHD medication when pregnant. Current data does not show significant risks to a developing baby during pregnancy if ADHD medications are taken, however more research is needed to understand these risks. We also know that untreated ADHD in pregnancy can increase the risk of complications such as pregnancy loss, early delivery, and mental health concerns in new parents. Deciding whether to continue ADHD medications in pregnancy can be complex and requires balancing risks and benefits of treatment. We do not know how pregnant people with ADHD approach this decision. Understanding this is important so healthcare providers can give patients the information they need to make the decision that is right for them. Therefore, we are asking: What influences birthing people in their decision-making regarding ADHD treatment in pregnancy? To answer this question, we will interview people in Ontario with ADHD who have been pregnant in the last year. We will analyze participants’ experiences using thematic analysis. Based on the results of this study we hope to create a written or virtual guide that will help future pregnant people with ADHD make informed decisions about their treatment. We will also provide recommendations to health providers about how to support patients in this process.